![Thomas Lingelbach](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Lingelbach
Directeur Général chez
VALNEVA SE
Fortune : 3 M $ au 31/05/2026
Profil
Thomas Lingelbach currently works at Valneva SE, as President, Chief Executive Officer & Director from 2023, Intercell Austria AG, as President & Chief Executive Officer from 2013, Grätzelmixer GmbH, as Chief Executive Officer from 2017, Vaccines Holdings Sweden AB, as Chairman from 2014, Valneva Sweden AB, as Chairman from 2015, Valneva Scotland Ltd., as Director from 2006, VALNEVA Austria GmbH, as Co-Managing Director from 2013, Valneva UK Ltd., as Director from 2015, and Valneva Canada, Inc., as Director from 2015.
Dr. Lingelbach also formerly worked at Intercell AG, as President & Chief Executive Officer from 2011 to 2013, Valneva Usa, Inc. (United States), as President, Chief Executive Officer & Director, Elatos GmbH, as Chief Executive Officer from 2013 to 2015, GSK Vaccines GmbH, as Managing Director & General Manager, Chiron Behring Gmbh & Co. Kg, as Managing Director, and Chiron Corp., as VP-Vaccines Global Industrial Operations from 1997 to 2005.
Dr. Lingelbach received his graduate degree from Technische Hochschule Mittelhessen.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VALNEVA SE 0,6 % | 31/12/2025 | 1 134 927 ( 0,6 % ) | 3 M $ | 31/05/2026 |
Postes actifs de Thomas Lingelbach
| Sociétés | Poste | Début |
|---|---|---|
| VALNEVA SE | Directeur Général | - |
Valneva Scotland Ltd.
 Valneva Scotland Ltd. BiotechnologyHealth Technology Engages in producing encephalitis vaccine | Directeur/Membre du Conseil | 01/12/2006 |
Valneva Austria GmbH
 Valneva Austria GmbH Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops and commercializes vaccines for infectious diseases | Directeur Général | 01/08/2013 |
Vaccines Holdings Sweden AB
 Vaccines Holdings Sweden AB BiotechnologyHealth Technology Develops and distributes vaccines and biological products | Président | 01/12/2014 |
Valneva UK Ltd.
 Valneva UK Ltd. Medical/Nursing ServicesHealth Services Provides health care services | Directeur/Membre du Conseil | 19/10/2015 |
Valneva Sweden AB
 Valneva Sweden AB BiotechnologyHealth Technology Manufactures vaccines and medicinal drugs | Président | 01/02/2015 |
Valneva Canada, Inc.
 Valneva Canada, Inc. Medical DistributorsDistribution Services Engages in marketing and distribution of vaccines | Directeur/Membre du Conseil | 01/01/2015 |
Intercell Austria AG | Directeur Général | 01/01/2013 |
Grätzelmixer GmbH | Directeur Général | 01/09/2017 |
Anciens postes connus de Thomas Lingelbach
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | - |
Formation de Thomas Lingelbach
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
65
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Intercell AG
 Intercell AG Pharmaceuticals: MajorHealth Technology Manufactures drugs and medicines | Health Technology |
Intercell USA, Inc.
 Intercell USA, Inc. BiotechnologyHealth Technology Discovers and develops vaccines and immune system stimulants | Health Technology |
Valneva Scotland Ltd.
Valneva Scotland Ltd. BiotechnologyHealth Technology Engages in producing encephalitis vaccine | Health Technology |
GSK Vaccines GmbH
 GSK Vaccines GmbH Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Technische Hochschule Mittelhessen
 Technische Hochschule Mittelhessen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Valneva SE
 Valneva SE BiotechnologyHealth Technology Develops and commercializes of prophylactic vaccines for infectious diseases | Health Technology |
Valneva Austria GmbH
Valneva Austria GmbH Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops and commercializes vaccines for infectious diseases | Commercial Services |
Elatos GmbH | |
Vaccines Holdings Sweden AB
Vaccines Holdings Sweden AB BiotechnologyHealth Technology Develops and distributes vaccines and biological products | Health Technology |
Valneva Sweden AB
Valneva Sweden AB BiotechnologyHealth Technology Manufactures vaccines and medicinal drugs | Health Technology |
Intercell Austria AG | |
Valneva UK Ltd.
Valneva UK Ltd. Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
Valneva Canada, Inc.
Valneva Canada, Inc. Medical DistributorsDistribution Services Engages in marketing and distribution of vaccines | Distribution Services |
Grätzelmixer GmbH |
